— Know what they know.
Not Investment Advice
Also trades as: SABS (NASDAQ) · $vol 2M

SABSW NASDAQ

SAB Biotherapeutics, Inc.
1W: -89.0% 1M: -92.1% 3M: -90.1% YTD: -96.5% 1Y: -95.8% 3Y: -97.8%
$0.00
-0.00 (-74.42%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $10514 mcap · 9M float · 1.34% daily turnover · Short 60% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 1.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99%), SAB Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $5.1M against a stock market value of $279.3M.
Distance to default 7.40 (Merton model): prices to 2026-10-21, balance sheet 2026-06-30, debt counted $2.9M (short-term plus half of long-term), stock volatility 60.6%; Altman Z'' 9.84. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
30
Growth
48
Value
42
Momentum
50
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.56
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-3.66
Bankruptcy prob: 2.5%
Low Risk
Credit Rating
BB-
Score: 36.0/100
Trend: Improving
Earnings Quality
—
OCF/NI: 5.34x
Accruals: 41.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SABSW scores -0.56, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SABSW scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SABSW's implied 2.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SABSW receives an estimated rating of BB- (score: 36.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
0.86x
PEG
0.00x
P/S
0.00x
P/B
1.14x
P/FCF
-0.01x
P/OCF
—
EV/EBITDA
10.23x
EV/Revenue
—
EV/EBIT
7.69x
EV/FCF
1.33x
Earnings Yield
-1251.44%
FCF Yield
-7121.16%
Shareholder Yield
0.88%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 0.9x earnings, SABSW trades at a deep value multiple.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.018
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.183
Assets / Equity
=
ROE
-11.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SABSW's ROE of -11.3% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1048 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
359.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alexandra Kropotova, MD
EVP, Chief Medical Officer
$525,000 $147,125 $921,575
Michael G. King,
Jr. EVP, Chief Financial Officer
$60,577 $— $721,988
Eddie J. Sullivan,
PhD. President
$377,200 $— $605,157
Samuel J. Reich
Chairman of the Board of Directors and Chief Executive Officer
$350,000 $— $565,798
Christoph Bausch, PhD
EVP, Chief Operating Officer
$325,000 $— $549,323

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $565,798
Avg Employee Cost (SGA/emp): $169,779
Employees: 86

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
86
+36.5% YoY
Revenue / Employee
—
Profit / Employee
$154,345
NI: $13,273,683
SGA / Employee
$169,779
Avg labor cost proxy
R&D / Employee
$399,446
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -30.0% -25.6% -41.3% -73.2% -53.8% -82.5% -1.0% -1.2% -95.5% -1.0% -1.2% -1.7% -81.9% -92.4% -1.3% 18.6% 15.0% -0.3% -11.3% -11.27%
ROA -14.2% -15.7% -25.9% -42.7% -28.4% -49.2% -61.7% -67.3% -62.6% -69.9% -82.8% -1.1% -53.2% -62.6% -80.5% 15.8% 12.2% -0.3% -9.5% -9.52%
ROIC -41.9% -41.8% -58.3% -76.2% -1.0% -1.4% -1.3% -1.2% -4.5% -2.3% -2.6% -3.7% -3.4% -2.2% -2.6% -71.5% -80.4% -36.5% -48.4% -48.38%
ROCE -13.4% -12.6% -29.6% -55.8% -56.1% -98.5% -1.2% -1.4% -57.3% -62.7% -73.6% -1.0% -93.3% -1.2% -1.9% 11.0% 8.3% -0.1% -5.5% -5.54%
Gross Margin 3.7% 1.0% -35.2% 74.7% 57.3% -58.9% -9.4% 22.3% -2.1% -1.1% -2.9% — -5.9% — — — — — — —
Operating Margin -66.4% -56.8% -1.0% -2.2% -3.6% -12.7% -75.7% -4.2% -61.9% -12.1% -38.8% — -87.3% — — — — — — —
Net Margin -1.0% 8.4% -75.2% -2.0% -3.6% -12.7% -80.5% -4.0% -74.9% -5.3% -27.9% — -99.3% — — — — — — —
EBITDA Margin -60.8% 15.5% -91.2% -1.7% -3.2% -10.9% -69.1% -3.2% -71.6% -3.1% -23.6% — -91.9% — — — — — — —
FCF Margin -65.5% -79.3% -79.4% -95.9% -1.0% -1.2% -2.3% -2.9% -11.3% -13.3% -13.5% -25.6% -26.2% -83.0% -267.4% -325.4% — — — —
OCF Margin -44.1% -63.1% -64.6% -82.4% -91.8% -1.1% -2.3% -2.8% -11.2% -13.2% -13.4% -25.4% -25.9% -82.4% -266.0% -324.9% — — — —
ROE 3Y Avg snapshot only -1.34%
ROE 5Y Avg snapshot only -1.18%
ROA 3Y Avg snapshot only -64.50%
ROIC Economic snapshot only -25.80%
Cash ROA snapshot only -28.63%
Cash ROIC snapshot only -58.16%
CROIC snapshot only -61.98%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -0.67 -0.21 -0.05 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 0.10 0.14 -4.81 -0.08 0.860
P/S Ratio 0.70 0.10 0.03 0.01 0.01 0.01 0.08 0.09 0.08 0.14 0.16 0.22 0.53 0.86 2.70 15.89 — — — 0.000
P/B Ratio 0.20 0.05 0.02 0.01 0.01 0.01 0.03 0.02 0.00 0.01 0.01 0.01 0.03 0.02 0.03 0.01 0.01 0.01 0.00 1.140
P/FCF -1.07 -0.12 -0.04 -0.01 -0.01 -0.01 -0.04 -0.03 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.05 -0.04 -0.04 -0.01 -0.014
P/OCF — — — — — — — — — — — — — — — — — — — —
EV/EBITDA 2.51 2.55 0.79 0.05 0.53 0.30 0.07 -0.11 1.32 1.10 0.90 0.63 0.53 0.19 -0.03 -4.65 -5.33 -33.79 10.23 10.233
EV/Revenue -1.53 -0.55 -0.29 -0.03 -0.37 -0.58 -0.26 0.63 -22.55 -14.70 -11.35 -16.89 -11.64 -15.20 8.85 -896.89 — — — —
EV/EBIT 2.30 2.02 0.66 0.05 0.44 0.26 0.06 -0.10 1.21 0.97 0.79 0.56 0.46 0.17 -0.03 -5.42 -6.57 603.34 7.69 7.691
EV/FCF 2.34 0.69 0.36 0.03 0.37 0.50 0.11 -0.22 1.99 1.10 0.84 0.66 0.44 0.18 -0.03 2.76 1.94 1.87 1.33 1.327
Earnings Yield -1.5% -4.8% -18.8% -83.2% -79.1% -149.3% -55.4% -74.2% -235.7% -110.6% -91.9% -136.7% -48.9% -105.7% -119.7% 10.3% 6.9% -20.8% -12.5% -12.51%
FCF Yield -93.0% -8.2% -28.4% -116.7% -101.8% -81.8% -27.9% -31.9% -141.4% -96.4% -85.8% -116.4% -49.6% -96.7% -99.1% -20.5% -23.9% -27.7% -71.2% -71.21%
PEG Ratio snapshot only 0.002
Price/Tangible Book snapshot only 0.005
Shareholder Yield snapshot only 0.88%
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.90 1.98 1.72 1.30 1.47 1.10 0.82 0.34 5.45 5.65 5.24 3.69 2.98 1.69 0.87 10.50 9.46 11.45 9.22 9.221
Quick Ratio 1.90 1.98 1.72 1.30 1.47 1.10 0.82 0.34 5.45 5.65 5.24 3.69 2.98 1.69 0.87 10.50 9.46 11.45 9.22 9.221
Debt/Equity 0.22 0.19 0.20 0.23 0.19 0.22 0.28 0.30 0.10 0.10 0.12 0.12 0.18 0.32 0.53 0.04 0.04 0.03 0.02 0.024
Net Debt/Equity -0.64 -0.36 -0.25 -0.04 -0.29 -0.31 -0.11 0.15 -0.88 -0.73 -0.69 -0.70 -0.62 -0.28 0.06 -0.63 -0.60 -0.45 -0.45 -0.454
Debt/Assets 0.10 0.11 0.13 0.14 0.12 0.13 0.16 0.16 0.07 0.08 0.09 0.08 0.11 0.18 0.21 0.03 0.03 0.02 0.02 0.022
Debt/EBITDA -1.27 -1.58 -0.69 -0.43 -0.35 -0.22 -0.22 -0.20 -0.15 -0.16 -0.15 -0.11 -0.16 -0.22 -0.19 0.28 0.36 2.10 -0.54 -0.544
Net Debt/EBITDA 3.67 3.00 0.86 0.07 0.54 0.30 0.09 -0.10 1.33 1.11 0.91 0.64 0.55 0.20 -0.02 -4.73 -5.45 -34.44 10.34 10.342
Interest Coverage -24.94 -16.90 -29.10 -38.84 -66.85 -88.74 -88.44 -82.62 -132.83 -132.21 -126.17 -139.03 -106.11 -109.00 -130.02 76.54 56.15 -0.70 -54.18 -54.185
Equity Multiplier 2.10 1.64 1.59 1.71 1.64 1.75 1.80 1.86 1.46 1.35 1.34 1.46 1.70 1.78 2.51 1.11 1.14 1.09 1.11 1.109
Cash Ratio snapshot only 8.768
Debt Service Coverage snapshot only -40.726
Cash to Debt snapshot only 19.998
FCF to Debt snapshot only -14.165
Defensive Interval snapshot only 548.4 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.14 0.34 0.49 0.62 0.36 0.23 0.14 0.10 0.03 0.05 0.06 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 1.38 1.94 3.04 2.53 3.52 2.02 1.29 0.63 0.81 5.44 9.44 31.18 48.13 3.52 1.02 0.35 0.00 0.00 0.00 0.000
Payables Turnover 2.39 2.14 3.89 3.67 2.56 3.53 1.15 1.13 1.62 3.58 3.83 4.13 3.60 1.89 1.77 1.48 1.29 1.02 0.70 0.704
DSO 264 188 120 144 104 181 284 577 453 67 39 12 8 104 358 1045 — — — —
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 153 171 94 99 143 103 317 322 225 102 95 88 101 193 206 246 282 357 518 518.1 days
Cash Conversion Cycle 112 17 26 45 -39 77 -34 255 228 -35 -57 -77 -94 -89 151 799 — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 1.2% -44.5% -78.0% -87.5% -90.6% -79.5% -56.7% -63.1% -40.9% -85.5% -95.9% -92.4% -1.0% -1.0% -1.0% -1.00%
Net Income — — — — -62.2% -1.6% -90.2% -21.4% -1.3% -47.2% -38.2% -67.5% 19.2% 14.0% 8.1% 1.4% 1.4% 98.8% 65.5% 65.52%
EPS — — — — -40.0% -1.3% -62.2% 0.3% -91.4% 19.7% 24.7% 5.2% 48.3% 14.5% 8.5% 1.0% 1.1% 99.8% 96.0% 95.98%
FCF — — — — -2.3% 18.2% 36.6% 62.8% -5.0% -1.3% -1.6% -2.3% -36.7% 9.7% 18.6% 3.8% -32.1% -69.6% -1.4% -1.37%
EBITDA — — — — -1.5% -4.1% -1.4% -37.8% -1.3% -38.7% -39.2% -74.3% 23.9% 12.5% 4.7% 1.5% 1.6% 1.1% 71.8% 71.79%
Op. Income — — — — -2.9% -1.1% -43.5% 4.7% -31.7% -42.0% -55.0% -91.3% -12.7% -0.5% 8.7% 16.6% -14.1% -37.6% -71.7% -71.74%
OCF Growth snapshot only -1.24%
Asset Growth snapshot only 6.91%
Equity Growth snapshot only 16.87%
Debt Growth snapshot only -20.05%
Shares Change snapshot only 7.58%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — -50.7% -74.5% -84.2% -84.8% — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -18.3% -17.3% -20.1% 51.7% 50.3% 79.9% 88.7% 88.72%
Assets 5Y — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -12.3% -19.6% -31.3% 75.3% 69.6% 1.1% 1.2% 1.22%
Book Value 3Y — — — — — — — — — — — — -31.9% -36.5% -46.9% -33.2% -26.3% -4.3% -11.7% -11.69%
Dividend 3Y — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.16 1.00 0.85 0.81 0.39 0.94 0.78 0.70 0.68 0.76 0.88 0.882
Earnings Stability — — — — — — — — 0.91 0.99 1.00 0.90 0.71 0.73 0.78 0.25 0.06 0.02 0.00 0.001
Margin Stability — — — — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.81 0.85 0.50 0.92 0.94 0.97 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.28 -0.07 0.07 0.02 -0.64 -0.67 -1.91 1.62 1.11 1.18 1.92 1.920
Gross Margin Trend — — — — — — — — -0.97 -1.17 -1.16 -2.49 -2.54 -8.03 -28.06 -25.40 — — — —
FCF Margin Trend — — — — — — — — -10.48 -12.37 -12.00 -23.74 -20.01 -75.73 -259.46 -311.17 — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — 18.6% 15.0% — — —
Internal Growth Rate — — — — — — — — — — — — — — — 18.8% 13.9% — — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.42 1.36 1.23 1.21 1.17 0.52 0.50 0.42 0.60 0.86 0.93 0.84 1.00 0.91 0.82 -1.99 -3.37 128.63 5.34 5.339
FCF/OCF 1.48 1.26 1.23 1.16 1.10 1.06 1.02 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.02 1.04 1.07 1.066
FCF/Net Income snapshot only 5.690
CapEx/Revenue 21.4% 16.3% 14.8% 13.4% 9.1% 6.5% 3.7% 6.0% 8.8% 11.7% 12.0% 23.1% 25.5% 55.1% 1.4% 48.3% — — — —
CapEx/Depreciation snapshot only 1.440
Accruals Ratio -0.08 0.06 0.06 0.09 0.05 -0.24 -0.31 -0.39 -0.25 -0.10 -0.06 -0.17 0.00 -0.06 -0.14 0.47 0.53 0.35 0.41 0.413
Sloan Accruals snapshot only 0.704
Cash Flow Adequacy snapshot only -15.207
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 2.5% 6.8% 20.5% 23.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 0.88%
Net Buyback Yield 0.0% 2.5% 6.8% 20.5% -9.1% -42.3% -14.6% -20.9% -375.2% -186.4% -153.1% -201.5% -2.9% -0.0% -0.0% -0.0% -88.2% -134.9% -343.9% -343.89%
Total Shareholder Return 0.0% 2.5% 6.8% 20.5% -9.1% -42.3% -14.6% -20.9% -375.2% -186.4% -153.1% -201.5% -2.9% -0.0% -0.0% -0.0% -88.2% -134.9% -343.9% -343.89%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.57 1.69 1.20 1.14 0.93 0.95 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 0.99 0.98 2.42 1.02 1.018
EBIT Margin -0.66 -0.27 -0.44 -0.60 -0.84 -2.25 -4.49 -6.56 -18.71 -15.21 -14.39 -29.91 -25.55 -89.89 -320.60 165.55 — — — —
Asset Turnover 0.14 0.34 0.49 0.62 0.36 0.23 0.14 0.10 0.03 0.05 0.06 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 2.10 1.64 1.59 1.71 1.90 1.68 1.66 1.76 1.53 1.48 1.48 1.57 1.54 1.48 1.58 1.17 1.22 1.15 1.18 1.183
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-2.66 $-2.31 $-3.57 $-5.21 $-3.72 $-5.37 $-5.79 $-5.19 $-7.12 $-4.31 $-4.36 $-4.92 $-3.68 $-3.69 $-3.99 $0.24 $0.22 $-0.01 $-0.16 $-0.16
Book Value/Share $8.87 $9.00 $8.63 $7.12 $6.16 $4.84 $3.91 $2.91 $9.67 $5.72 $4.98 $3.99 $2.80 $2.30 $1.29 $2.12 $2.47 $4.24 $2.69 $2.69
Tangible Book/Share $8.87 $9.00 $8.63 $7.12 $6.16 $4.84 $3.91 $2.91 $9.67 $5.72 $4.98 $3.99 $2.80 $2.30 $1.29 $2.12 $2.47 $4.24 $2.69 $2.69
Revenue/Share $2.54 $4.99 $6.79 $7.62 $4.74 $2.52 $1.27 $0.78 $0.38 $0.28 $0.30 $0.16 $0.14 $0.04 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.67 $-3.96 $-5.39 $-7.31 $-4.78 $-2.94 $-2.92 $-2.23 $-4.27 $-3.76 $-4.07 $-4.19 $-3.74 $-3.37 $-3.30 $-0.48 $-0.75 $-0.99 $-0.91 $-0.91
OCF/Share $-1.12 $-3.15 $-4.39 $-6.28 $-4.35 $-2.78 $-2.87 $-2.19 $-4.24 $-3.73 $-4.03 $-4.15 $-3.70 $-3.35 $-3.28 $-0.48 $-0.73 $-0.96 $-0.86 $-0.86
Cash/Share $7.64 $4.89 $3.86 $1.94 $2.99 $2.59 $1.54 $0.46 $9.54 $4.77 $4.03 $3.28 $2.24 $1.38 $0.61 $1.42 $1.57 $2.01 $1.29 $1.29
EBITDA/Share $-1.55 $-1.07 $-2.49 $-3.90 $-3.35 $-4.97 $-5.00 $-4.41 $-6.43 $-3.76 $-3.79 $-4.36 $-3.13 $-3.27 $-3.60 $0.28 $0.27 $0.05 $-0.12 $-0.12
Debt/Share $1.96 $1.68 $1.72 $1.66 $1.18 $1.08 $1.11 $0.89 $1.00 $0.59 $0.58 $0.49 $0.50 $0.73 $0.69 $0.08 $0.10 $0.12 $0.06 $0.06
Net Debt/Share $-5.68 $-3.21 $-2.14 $-0.27 $-1.81 $-1.51 $-0.44 $0.42 $-8.55 $-4.18 $-3.46 $-2.80 $-1.74 $-0.65 $0.08 $-1.34 $-1.48 $-1.89 $-1.22 $-1.22
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — -0.558
Altman Z-Prime snapshot only 0.258
Piotroski F-Score 2 1 1 1 2 1 1 1 3 3 4 3 0 1 1 4 4 3 3 3
Beneish M-Score — — — — -1.30 -7.63 -10.07 -5.69 -14.97 -2.50 -0.28 — -2.88 — — — — — — —
Ohlson O-Score snapshot only -3.660
ROIC (Greenblatt) snapshot only -10.83%
Net-Net WC snapshot only $1.06
EVA snapshot only $-68469409.44
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 31.70 32.70 32.70 29.45 30.45 28.10 25.55 21.80 36.00 36.00 36.00 36.00 35.55 31.70 24.05 65.50 65.50 33.00 36.00 36.000
Credit Grade snapshot only 13
Credit Trend snapshot only 11.950
Implied Spread (bps) snapshot only 550.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms